January 23, 2012
If you read the patent literature during the course of your work, ACS is looking for you! Please consider writing informed summaries of newly published patents for Patent Watch. If you’re interested, contact firstname.lastname@example.org for details.
Improve the synthesis of cell-proliferation inhibitors. Inventors J. Merten, S. Renner, and C. Reichel report compounds such as 1 that are intermediates in the synthesis of indolinone drugs that are used to inhibit cell proliferation. Their claims cover 1 and the process for making it (shown in Figure 1). The reaction is carried out by heating a solution of 2 and Ac2O to reflux in toluene, adding trimethyl orthobenzoate, and distilling volatile reaction products. After workup, 1 is isolated as yellow crystals in yields up to 91.7%. Complete elemental analysis indicates that the product is very pure. 1H and 13C NMR data are provided.
The inventors also claim the preparation of 2 (Figure 2), which begins with the esterification of 3 to form 4, isolated in 88.8% yield with 99.8% purity by HPLC. The ester is treated with dimethyl malonate in the presence of the strong base sodium tert-amylate to form 5 in 95.4% yield and 99.9% purity (HPLC). (NMP is N-methylpyrrolidone.) Compound 5 is reductively cyclized with hydrogen over a Pd/C catalyst; 6 is obtained in 87.2% yield and 99.8% purity (HPLC).
In the last step, 6 is treated with chloroacetic anhydride to produce 2, isolated in 93.5% yield. 1H and 13C NMR data and full elemental analysis of the product are reported. The first three steps shown in Figure 2 are carried out on a multikilogram scale, indicating that this part of the process is suitable for commercial operation. The inventors describe alternative methods for preparing 6 and claim that their method is superior.
The claims include the use of 1 to prepare intermediate 7, as shown in Figure 3. Treating 1 with base converts it to 8 in 94.6% yield; it then reacts with 9 to give 7 in isolated 88.1% yield. Although the purity of 7 and 8 is not reported, full elemental analysis and NMR data are given for each compound.
Finally, the inventors describe the preparation of 9 (Figure 4). The first step is the reaction of 10 with chloroacetic anhydride to give 11, which is recovered in 92.7% yield and then condensed with N-methylpyrazine to form 12. This is not isolated; instead, the reaction mixture is washed with water and diluted with i-PrOH. The mixture is hydrogenated over a Pd/C catalyst to give 9 in 88% isolated yield. Again, the purity of 9 and 11 is not reported, but full elemental analysis and NMR data are provided.
(Boehringer Ingelheim International GmbH [Ingelheim am Rhein, Germany]. US Patent 8,067,617, Nov. 29, 2011; Keith Turner)
What do you think of Patent Watch? Let us know.